Search DubaiPRNetwork.com

Home >> Banking & Investments

Dubai Investments acquires stake in Globalpharma for 100% ownership

Thursday, February 7, 2019/ Editor -  

Share

Home >> Banking & Investments

Dubai, February 7, 2019: Dubai Investments PJSC [DFM: DIC], the diversified leading company listed on the Dubai Financial Market, today announced the acquisition of an additional 66% stake in Globalpharma. Following the acquisition, made through Dubai Investments Industries, the pharmaceuticals company will now be a wholly owned subsidiary of Dubai Investments.

In 2014, Dubai Investments divested a 66% stake and had continued to hold a minority 34% equity in the subsidiary.
  
Khalid Bin Kalban, Managing Director and CEO of Dubai Investments PJSC, said: “Our original investment in Globalpharma was well timed and good for the growth of the healthcare sector in the UAE and region. We see the strategic benefit for making this acquisition. It forms part of the Dubai Investments growth strategy, and underscores our commitment to creating more value for our shareholders. 

“Our healthcare portfolio includes different stakes in KCH Healthcare LLC, Clemenceau Medical Centre, tie ups with hospital operators such as NMC in Dubai Investments Park and Mirdif Hills. These investments not only achieve key business objectives for Dubai Investments and support the Dubai economy, they also contribute to the wellbeing of the UAE, improve the reputation of Dubai as a hub for world-class medical care and align with the long term plans of the UAE government for sustainability and progress in fields such as health and science.”

Established in 1998 and headquartered in Dubai Investments Park, Globalpharma grew to become a market leader in certain generic medicines with a strong regional footprint. Globalpharma manufactures and markets pharmaceutical products in more than 14 countries across the GCC, Middle East and neighbouring markets.

Globalpharma manufactures and commercializes pharmaceutical products under CGMP (current good manufacturing practice) conditions including antibiotics, cardiovascular, anti-ulcerants, analgesic, NSAIDs (Nonsteroidal anti-inflammatory drugs), food supplements, vitamins, anti-diabetics, respiratory products and anti-histamine formulations. 


Previous in Banking & Investments

Next in Banking & Investments


Home >> Banking & Investments Section

Latest Press Release

Cap on sulphur emissions to drive global demand for LNG as shipping fuel

Discovery Powers Mobile Malaria Research

American Aesthetic Medical Center on empowering spree to celebrate Emirati Women ...

GUESS – The Red and Black Trend

NYU Abu Dhabi researchers find warm ocean water, exacerbated by warmer air, is c ...

GEMS Education's GCSE students celebrate outstanding results

Robotics & Automation to transform Middle East's warehousing & inventory control ...

Ericsson announces changes to the Executive Team

Ikea 2020 Catalogue Launches With a Fresh Start

Epson announces its first 24-inch dye sublimation printer, the SureColor SC-F500

The Boot Edit

Comments of Dr Azad Moopen, Founder Chairman and Managing Director, Aster DM Hea ...

Shaza Hotels Expands Presence in UAE with the Opening of Al Badayer Oasis – A Sh ...

Al-Futtaim Engineering and Technologies signs up as strategic corporate partner ...

UAE Team Emirates Heads to Germany for Euroeyes Cyclassics Hamburg and Deutschla ...

Ma'an Rolls Out New Program to Get Abu Dhabi Community Involved in Making a Soci ...

GEMS Education student is the first UAE qualifier for trials to India's FIFA U17 ...

Red Hat Recognized as a Leader by Independent Research Firm in Infrastructure Au ...

Group Art Exhibition by 2XL Furniture & Home Décor to Bring Together 100 Artist ...

Biggest Japan buying of Italian bonds since 2014